5 results
Comment to Drs Gastaldon, Papola, Ostuzzi and Barbui
- Part of
-
- Journal:
- Epidemiology and Psychiatric Sciences / Volume 29 / 2020
- Published online by Cambridge University Press:
- 29 April 2020, e124
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
142 Withdrawal Symptom Assessment in an Esketamine Safety Study in Patients with Treatment-resistant Depression
-
- Journal:
- CNS Spectrums / Volume 25 / Issue 2 / April 2020
- Published online by Cambridge University Press:
- 24 April 2020, p. 290
-
- Article
-
- You have access
- Export citation
118 Use of Patient Health Questionnaire to Predict Relapses in Patients with Treatment-resistant Depression Treated With Esketamine + Oral Antidepressant
-
- Journal:
- CNS Spectrums / Volume 25 / Issue 2 / April 2020
- Published online by Cambridge University Press:
- 24 April 2020, pp. 276-277
-
- Article
-
- You have access
- Export citation
119 Assessment of Health-Related Quality of Life and Health Status in Patients with Treatment-resistant Depression
-
- Journal:
- CNS Spectrums / Volume 25 / Issue 2 / April 2020
- Published online by Cambridge University Press:
- 24 April 2020, pp. 277-278
-
- Article
-
- You have access
- Export citation
156 Improvement in Disease Severity in Patients With Treatment-Resistant Depression Following Treatment With Intranasal Esketamine
-
- Journal:
- CNS Spectrums / Volume 23 / Issue 1 / February 2018
- Published online by Cambridge University Press:
- 15 June 2018, pp. 95-96
-
- Article
-
- You have access
- Export citation